![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 04, 2018 9:33:21 AM
Months ago several supporters in this group tried to deflect doubt by stating RBII isn't even a pharmaceutical or marijuana company (!), that this is a "licensing" play. Meaning the company would not manufacture or produce marijuana into "Cannophen" but would only seek to license it to other companies.
So the fact there is NO licensing after all this time just proves no other company in their right mind would pay to produce or sell "Cannophen" for RBII. Because there's nothing proprietary.
At most, this is a company putting out vanity products (serums, menthol pain creams, etc.) with just enough effort to appear "legitimate" to flirt on the edge of the marijuana sector.
BUT HEY HOW ABOUT THOSE "MASSIVE REVENUES" FROM THAT GROUNDBREAKING SCAR SERUM BEING SOLD ON AMAZON?
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM